GlaxoSmithKline Pharma Q1 net profit rises 11% to Rs 132 crore
The drug maker had reported a net profit of Rs 119 crore in the April-June quarter of the last fiscal.
)
GlaxoSmithKline Pharmaceuticals on Wednesday said its consolidated net profit increased by 11 per cent to Rs 132 crore for the first quarter ended June 30.
The drug maker had reported a net profit of Rs 119 crore in the April-June quarter of the last fiscal.
Its total income rose to Rs 798 crore in the first quarter against Rs 773 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing.
"Despite the strong external headwinds, GSK remains focused on delivering best-in-class competitive performance and driving operational efficiencies. We remain committed to explore new growth opportunities and improving our leadership in key therapy areas," GlaxoSmithKline Pharmaceuticals MD Bhushan Akshikar said.
Shares of the company were trading 0.3 per cent down at Rs 1,399.20 apiece on the BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
07:54 PM IST
Q4 Results 2022: GlaxoSmithKline, Greenply Industries, Century Plyboards, Raymond announce March quarter results; here are key highlights
Stocks in Focus on May 27: Manpasand Beverages, GMR Infra to NBCC; here are the 5 newsmakers of the day
Unilever gets the taste of Horlicks, will acquire GSK health food portfolio for 3.1 bn pound
Breaking the mould: GSK picks Big Pharma's first female CEO